KITADA CHIEKO
No ORCID on file
· 9 papers in corpus
lab-animal
2011
Metastin, compounds that promote the activity of metastin or its receptors and the like are excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropic hormone secretion promoters, gonadotropic hormone secreti…
2010
Metastin, compounds that promote the activity of metastin or its receptors and the like are excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropic hormone secretion promoters, gonadotropic hormone secreti…
2006
Metastin, compounds that promote the activity of metastin or its receptors and the like are excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropic hormone secretion promoters, gonadotropic hormone secreti…
2004
Metastin and compounds promoting the activity of metastin or its receptor are useful as excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropin secretion promoters, gonadotropin secretion inhibitors, sexua…
2004
Metastin and compounds promoting the activity of metastin or its receptor ar e useful as excellent gonadal function improving agents, ovulation inducers or promoters, gonadotropin secretion promoters, gonadotropin secretion inhibitors, sexu…
2000
PCT No. PCT/JP96/01140 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/34012 PCT Pub. Date Oct. 31, 1996The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and n…
1998
The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and novel cyclic pentapeptide or salts thereof are provided. The LH-RH receptor antagonists of the present invention are effective as medicines for preventing a…
1997
PROBLEM TO BE SOLVED: To obtain an antagonist, a new cyclic pentapeptide (salt), having a specific amino acid sequence, presenting LH-RH receptor antagonistic action, thus useful for preventing and treating e.g. prostate cancer, uterine can…
1996
The LH-RH receptor antagonists containing cyclic pentapeptides or salts thereof and novel cyclic pentapeptide or salts thereof are provided. The LH-RH receptor antagonists of the present invention are effective as medicines for preventing a…